{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:25:12Z","timestamp":1769599512876,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.clml.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T07:58:40Z","timestamp":1512547120000},"page":"e85-e93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Transplantation in the Treatment of Primary Cutaneous Aggressive Epidermotropic Cytotoxic CD8-Positive T-Cell Lymphoma"],"prefix":"10.1016","volume":"18","author":[{"given":"Benoit M.","family":"Cyrenne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet Fraser","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Isufi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Seropian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2017.11.004_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.11.004_bib2","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2008"},{"key":"10.1016\/j.clml.2017.11.004_bib3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health\u00a0Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.11.004_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/modpathol.2016.240","article-title":"Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas","volume":"30","author":"Guitart","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clml.2017.11.004_bib5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2340\/00015555-2102","article-title":"CD4\/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell lymphoma?","volume":"95","author":"Miyauchi","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clml.2017.11.004_bib6","first-page":"78","article-title":"Primary cutaneous aggressive epidermotropic CD4\/CD8 double-negative cytotoxic T-cell lymphoma","volume":"104","author":"Akkari","year":"2012","journal-title":"Pathologica"},{"key":"10.1016\/j.clml.2017.11.004_bib7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A\u00a0variant of lymphomatoid papulosis\u00a0simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2017.11.004_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000087025","article-title":"Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement","volume":"211","author":"Marzano","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.clml.2017.11.004_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2011.07.043","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation","volume":"67","author":"Nofal","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.clml.2017.11.004_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0190-9622(90)70074-R","article-title":"Cutaneous T cell lymphoma with suppressor\/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes","volume":"22","author":"Agnarsson","year":"1990","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.clml.2017.11.004_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clml.2017.11.004_bib12","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMcpc0706687","article-title":"Case records of the Massachusetts General Hospital. Case 38-2007. A 44-year-old woman with generalized, painful, ulcerated skin lesions","volume":"357","author":"Liu","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2017.11.004_bib13","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1111\/j.1365-2230.2009.03754.x","article-title":"Aggressive epidermotropic cutaneous CD8+ (Berti's) lymphoma","volume":"35","author":"Webber","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clml.2017.11.004_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1442-200X.2011.03369.x","article-title":"Six-year-old girl with primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma","volume":"53","author":"Kikuchi","year":"2011","journal-title":"Pediatr Int"},{"key":"10.1016\/j.clml.2017.11.004_bib15","first-page":"39","article-title":"Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma - a case series of the ADF working group \u201ccutaneous lymphomas.\u201d","volume":"12","author":"Moritz","year":"2014","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.clml.2017.11.004_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/bjd.13792","article-title":"Successful stem cell transplantation in a patient with primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma","volume":"173","author":"Wehkamp","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clml.2017.11.004_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/his.12371","article-title":"Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop","volume":"67","author":"Robson","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.clml.2017.11.004_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.pathol.2016.08.014","article-title":"Epidermotropic CD8 positive lymphoproliferative diseases: histological and immunophenotypic similarities but markedly differing clinical behaviour","volume":"48","author":"Paton","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.clml.2017.11.004_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jdcr.2017.02.004","article-title":"Complete durable remission of a fulminant primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma after autologous and allogeneic hematopoietic stem cell transplantation","volume":"3","author":"Plachouri","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clml.2017.11.004_bib20","first-page":"440","article-title":"Successful autologous peripheral blood stem cell transplantation in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma","volume":"15","author":"Saruta","year":"2017","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.clml.2017.11.004_bib21","series-title":"Rare Malignant Skin Tumors","first-page":"291","article-title":"Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma","author":"Kempf","year":"2015"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017308819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017308819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:08Z","timestamp":1761870668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265017308819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2152265017308819"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2017.11.004","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplantation in the Treatment of Primary Cutaneous Aggressive Epidermotropic Cytotoxic CD8-Positive T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}